You currently have Javascript disabled. To login you must enable Javascript in your browser. Please update your relevant browser settings. Investor Centre Company Overview Atomo is a medical device company headquartered in Sydney, Australia, and is establishing an in-house assembly and packing facility in South Africa, and has a commercial office in the UK. Established in 2010, the Company’s primary focus is the expansion of global sales and continued development of its proprietary rapid test device technologies that simplify testing processes and reduce errors compared to more complex conventional bloodbased rapid diagnostic testing (RDT) kits. Atomo is a public company incorporated in Australia. It successfully raised A$30 million through an initial public offering with quotation of its shares commencing on ASX on 16 April 2020 under ASX Code AT1. View ProspectusOpens in new window Share Price Performance Historical Share Price $0.30 Open 0.31 High 0.31 Low 0.30 Volume 3,388,739 Down -0.01 -0.01 (Down -1.6% (-1.6%) As at 4:00PM 15/01/2021 Investor Contacts Investor Relations Atomo Diagnostics Limited Level 12, 680 George Street, Sydney NSW 2000 Ph: +61 477 858 444 investorqueries@atomodiagnostics.com Share Registry Link Market Services Locked Bag A14, Sydney South NSW 1235 Ph: 1300 554 474 registrars@linkmarketservices.com.au